Florida Clinical Trials Group.

Plantation, Florida 33322

6 studies enrolling now · 6 studies all time

What they study most

Advanced Metastatic Cancer, Breast Cancer, Cancer, Carcinoma, Non-Small-Cell Lung, Castration-resistant Prostate Cancer (CRPC), ER+, HER 2- Breast Cancer, Hepatocellular Carcinoma (HCC), Microsatellite Stable (MSS) Colorectal Carcinoma, Multiple Myeloma (MM), Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, Polycythemia Vera

Studies at this site

• A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4) — Recruiting now
• INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV) — Recruiting now
• A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors — Recruiting now
• A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma — Recruiting now
• Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors — Recruiting now
• Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma — Recruiting now